These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 27384589)

  • 1. Turning on the Radio: Epigenetic Inhibitors as Potential Radiopriming Agents.
    Oronsky B; Scicinski J; Kim MM; Cabrales P; Salacz ME; Carter CA; Oronsky N; Lybeck H; Lybeck M; Larson C; Reid TR; Oronsky A
    Biomolecules; 2016 Jul; 6(3):. PubMed ID: 27384589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic mechanisms underlying prostate cancer radioresistance.
    Macedo-Silva C; Benedetti R; Ciardiello F; Cappabianca S; Jerónimo C; Altucci L
    Clin Epigenetics; 2021 Jun; 13(1):125. PubMed ID: 34103085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pivotal role of DNA methylation in the radio-sensitivity of tumor radiotherapy.
    Zhu X; Wang Y; Tan L; Fu X
    Cancer Med; 2018 Aug; 7(8):3812-3819. PubMed ID: 29952116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unraveling Mitochondrial Determinants of Tumor Response to Radiation Therapy.
    Zaffaroni M; Vincini MG; Corrao G; Marvaso G; Pepa M; Viglietto G; Amodio N; Jereczek-Fossa BA
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nrf2 is a potential therapeutic target in radioresistance in human cancer.
    Zhou S; Ye W; Shao Q; Zhang M; Liang J
    Crit Rev Oncol Hematol; 2013 Dec; 88(3):706-15. PubMed ID: 24126138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA methylome analysis identifies epigenetic silencing of FHIT as a determining factor for radiosensitivity in oral cancer: an outcome-predicting and treatment-implicating study.
    Lin HY; Hung SK; Lee MS; Chiou WY; Huang TT; Tseng CE; Shih LY; Lin RI; Lin JM; Lai YH; Chang CB; Hsu FC; Chen LC; Tsai SJ; Su YC; Li SC; Lai HC; Hsu WL; Liu DW; Tai CK; Wu SF; Chan MW
    Oncotarget; 2015 Jan; 6(2):915-34. PubMed ID: 25460508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of DNA and RNA Methylation on Radiobiology and Cancer Progression.
    Chi HC; Tsai CY; Tsai MM; Lin KH
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29439529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deciphering the epigenetic network in cancer radioresistance.
    Cabrera-Licona A; Pérez-Añorve IX; Flores-Fortis M; Moral-Hernández OD; González-de la Rosa CH; Suárez-Sánchez R; Chávez-Saldaña M; Aréchaga-Ocampo E
    Radiother Oncol; 2021 Jun; 159():48-59. PubMed ID: 33741468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic therapy for solid tumors: from bench science to clinical trials.
    Juo YY; Gong XJ; Mishra A; Cui X; Baylin SB; Azad NS; Ahuja N
    Epigenomics; 2015; 7(2):215-35. PubMed ID: 25942532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetics as a determinant of radiation response in cancer.
    Arechaga-Ocampo E
    Int Rev Cell Mol Biol; 2024; 383():145-190. PubMed ID: 38359968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic therapy and chemosensitization in solid malignancy.
    Ronnekleiv-Kelly SM; Sharma A; Ahuja N
    Cancer Treat Rev; 2017 Apr; 55():200-208. PubMed ID: 28431263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic regulation and cancer (review).
    Chen QW; Zhu XY; Li YY; Meng ZQ
    Oncol Rep; 2014 Feb; 31(2):523-32. PubMed ID: 24337819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiosensitization by targeting radioresistance-related genes with protein kinase A inhibitor in radioresistant cancer cells.
    Chin C; Bae JH; Kim MJ; Hwang JY; Kim SJ; Yoon MS; Lee MK; Kim DW; Chung BS; Kang CD; Kim SH
    Exp Mol Med; 2005 Dec; 37(6):608-18. PubMed ID: 16391522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic modulation with histone deacetylase inhibitors in combination with immunotherapy.
    Park J; Thomas S; Munster PN
    Epigenomics; 2015; 7(4):641-52. PubMed ID: 26111034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic inhibitors.
    Verma M; Banerjee HN
    Methods Mol Biol; 2015; 1238():469-85. PubMed ID: 25421675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia.
    Dobosy JR; Roberts JL; Fu VX; Jarrard DF
    J Urol; 2007 Mar; 177(3):822-31. PubMed ID: 17296351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Epigenetics and cancer].
    Xue C; Yu J; Liu H; Chen J
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2009 Oct; 26(5):1133-6. PubMed ID: 19947505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetics in cancer: what's the future?
    Boumber Y; Issa JP
    Oncology (Williston Park); 2011 Mar; 25(3):220-6, 228. PubMed ID: 21548464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockdown of microRNA-1323 restores sensitivity to radiation by suppression of PRKDC activity in radiation-resistant lung cancer cells.
    Li Y; Han W; Ni TT; Lu L; Huang M; Zhang Y; Cao H; Zhang HQ; Luo W; Li H
    Oncol Rep; 2015 Jun; 33(6):2821-8. PubMed ID: 25823795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Epigenetic Reprogramming Strategy to Resensitize Radioresistant Prostate Cancer Cells.
    Peitzsch C; Cojoc M; Hein L; Kurth I; Mäbert K; Trautmann F; Klink B; Schröck E; Wirth MP; Krause M; Stakhovsky EA; Telegeev GD; Novotny V; Toma M; Muders M; Baretton GB; Frame FM; Maitland NJ; Baumann M; Dubrovska A
    Cancer Res; 2016 May; 76(9):2637-51. PubMed ID: 26984757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.